Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Mammana

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Annals of Clinical and Translational Neurology|March 7, 2020
Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patientsAngela Mammana, Simone Baiardi, Marcello Rossi, et al.
Alzheimer'S Research & Therapy|September 8, 2023
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementiasGiuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo, et al.
Journal of Neurology|September 22, 2019
Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuICSamir Abu-Rumeileh, Simone Baiardi, Barbara Polischi, et al.
Clinical Chemistry and Laboratory Medicine|March 8, 2024
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantificationAngela Mammana, Simone Baiardi, Marcello Rossi, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 5, 2021
Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementiaAndrea Mastrangelo, Simone Baiardi, Corrado Zenesini, et al.
International Journal of Molecular Sciences|May 25, 2024
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive DementiaGiuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo, et al.
Alzheimer'S Research & Therapy|September 10, 2024
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?Giuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo, et al.
Brain : a Journal of Neurology|March 8, 2023
Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque typeSimone Baiardi, Angela Mammana, Sofia Dellavalle, et al.
Acta Neuropathologica|January 19, 2024
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burdenGiuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 15, 2020
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion diseaseSamir Abu-Rumeileh, Simone Baiardi, Anna Ladogana, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Annals of Clinical and Translational Neurology|March 7, 2020
Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patientsAngela Mammana, Simone Baiardi, Marcello Rossi, et al.
Alzheimer'S Research & Therapy|September 8, 2023
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementiasGiuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo, et al.
Journal of Neurology|September 22, 2019
Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuICSamir Abu-Rumeileh, Simone Baiardi, Barbara Polischi, et al.
Clinical Chemistry and Laboratory Medicine|March 8, 2024
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantificationAngela Mammana, Simone Baiardi, Marcello Rossi, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 5, 2021
Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementiaAndrea Mastrangelo, Simone Baiardi, Corrado Zenesini, et al.
International Journal of Molecular Sciences|May 25, 2024
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive DementiaGiuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo, et al.
Alzheimer'S Research & Therapy|September 10, 2024
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?Giuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo, et al.
Brain : a Journal of Neurology|March 8, 2023
Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque typeSimone Baiardi, Angela Mammana, Sofia Dellavalle, et al.
Acta Neuropathologica|January 19, 2024
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burdenGiuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 15, 2020
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion diseaseSamir Abu-Rumeileh, Simone Baiardi, Anna Ladogana, et al.
Pageof 8